Literature DB >> 1932302

Reticulocyte counting in thalassemic and other conditions with the R-1000 Sysmex analyzer.

G S Paterakis1, E Voskaridou, A Loutradi, J Rombos, D Loukopoulos.   

Abstract

Precise reticulocyte counts are difficult to obtain by the manual method when their percentage in the blood is low or normal. In these instances, rapid reticulocyte counting by flow cytometry appears to offer more accuracy and precision. The purpose of this study was to establish reticulocyte counts in heterozygous beta-thalassemia for reference purposes and to evaluate the performance of the recently introduced apparatus R-1000 (Sysmex) in the very heterogeneous thalassemic and sickle-cell syndromes. We studied a total of 364 samples; 102 heterozygous beta-thalassemia carriers, 180 normal matched controls, 36 patients with thalassemia major or intermedia, and 46 patients with various sickle-cell syndromes. Reticulocyte counts (both as percentage and as total number) were higher in heterozygous beta-thalassemia than in normal controls (p less than 0.001) and showed an inverse correlation with the respective hemoglobin values (p less than 0.001). These results confirm the proposed slightly increased erythropoietic activity in heterozygous beta-thalassemia carriers. A drawback of the technique is that the reticulocyte-platelet discrimination error is signaled frequently in all conditions displaying a marked red cell heterogeneity, especially when these are associated with high reticulocyte numbers. This calls probably for readjustment of the corresponding algorithm. In addition, all these conditions show a significantly increased auramine-O mature red-cell nonspecific fluorescence.

Entities:  

Mesh:

Year:  1991        PMID: 1932302     DOI: 10.1007/bf01703447

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  16 in total

1.  Evaluation of reticulocyte counts by flow cytometry in a routine laboratory.

Authors:  D J Ferguson; S F Lee; P A Gordon
Journal:  Am J Hematol       Date:  1990-01       Impact factor: 10.047

2.  Evaluation of the Sysmex R-1000. An automated reticulocyte analyzer.

Authors:  A Tichelli; A Gratwohl; A Driessen; S Mathys; E Pfefferkorn; A Regenass; P Schumacher; C Stebler; M Wernli; C Nissen
Journal:  Am J Clin Pathol       Date:  1990-01       Impact factor: 2.493

3.  Flow cytometric reticulocyte quantification using thiazole orange provides clinically useful reticulocyte maturity index.

Authors:  B H Davis; N C Bigelow
Journal:  Arch Pathol Lab Med       Date:  1989-06       Impact factor: 5.534

4.  Enumeration of reticulocytes using fluorescence-activated flow cytometry.

Authors:  L Corash; M Rheinschmidt; S Lieu; P Meers; E Brew
Journal:  Pathol Immunopathol Res       Date:  1988

5.  Flow cytometric reticulocyte counting with thioflavin T in a clinical hematology laboratory.

Authors:  D K Metzger; S Charache
Journal:  Arch Pathol Lab Med       Date:  1987-06       Impact factor: 5.534

6.  Simultaneous reticulocyte and platelet counting on a clinical flow cytometer.

Authors:  W P Vaughan; J Hall; K Johnson; C Dougherty; D Peebles
Journal:  Am J Hematol       Date:  1985-04       Impact factor: 10.047

7.  [Platelet volume: comparative study of 2 populations of Greek and French origin].

Authors:  P E Makris; S Sklavunu-Zurukzoglu; A Ballas; W Zurukzoglu
Journal:  Nouv Rev Fr Hematol       Date:  1982

8.  An automated optoelectronic reticulocyte counter.

Authors:  K Kojima; M Niri; K Setoguchi; I Tsuda; N Tatsumi
Journal:  Am J Clin Pathol       Date:  1989-07       Impact factor: 2.493

9.  Flow cytometry of reticulocytes applied to clinical hematology.

Authors:  H J Tanke; P H Rothbarth; J M Vossen; G J Koper; J S Ploem
Journal:  Blood       Date:  1983-06       Impact factor: 22.113

10.  Thiazole orange: a new dye for reticulocyte analysis.

Authors:  L G Lee; C H Chen; L A Chiu
Journal:  Cytometry       Date:  1986-11
View more
  2 in total

Review 1.  Reticulocytes and reticulocyte enumeration.

Authors:  R S Riley; J M Ben-Ezra; R Goel; A Tidwell
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

2.  The appearance of reticulocytes with medium or high RNA content is a sensitive indicator of beginning granulocyte recovery after aplasiogenic cytostatic drug therapy in patients with AML.

Authors:  R Kuse
Journal:  Ann Hematol       Date:  1993-04       Impact factor: 3.673

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.